According to a paper, results point to a variety of processes, perhaps related to the heterogeneity of CD34+ cells, which underlie the apoptosis induced in CD34+ CML cells. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.